Search Results 311-320 of 15210 for TNF

1. A Study to Assess Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients with Crohn's Disease - Mayo Clinic

   ... TNF-α antagonist or vedolizumab or ustekinumab, or having documented intolerance. Women of childbearing potential (WCBP) must have negative serum pregnancy ...

2. A Study to Evaluate the Effectiveness of a Dexamethasone Eluting Slim Modiolar Electrode in the Reduction of Fibrosis in a Newly Implanted Adult Population with Bilateral, Post-Linguistic, Moderate to Profound Sensorineural Hearing Loss - Mayo Clinic

   A Study to Evaluate the Effectiveness of a Dexamethasone Eluting Slim Modiolar Electrode in the Reduction of Fibrosis in a Newly Implanted Adult Population ...

3. A Study of HFB200301 in Adult Patients With Advanced Solid Tumors - Mayo Clinic

   - Prior exposure to agents targeting the Tumor Necrosis Factor Receptor type 2 (TNFR2) receptor - Active autoimmune disease requiring systemic treatment in ...

4. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

   ... tumor necrosis factor [anti-TNF] agents) is allowed, provided the following is met: minimum of 2 weeks prior to Cycle 1, Day 1. Patients who have received ...

5. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

   ... TNF-alpha agents) within 2 weeks prior to initiation of study treatment, or anticipation of need for systemic immunosuppressive medication during study ...

6. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

   Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 1; 61 (3):409-17 ...

7. A Study to Evaluate the Safety, Tolerability, and Activity of Escalating Doses of AK002 in Patients with Eosinophilic Gastritis (EG) and/or Eosinophilic Gastroenteritis (EGE) - Mayo Clinic

   ... TNF, anti-IL-5, anti-IL-5 receptor, dupilumab, anti-IgE antibodies, omalizumab) or systemic corticosteroids with a daily dose >10 mg of prednisone or ...

8. Malignant Peripheral Nerve Sheath Tumors (MPNST) Clinical Trials - Mayo Clinic Research

   A Study of Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumors that are Recurrent or Cannot Be Removed by Surgery Rochester, ...

9. Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) - Mayo Clinic

   For subjects being administered biologic treatments (eg, Anti-TNF or anti-integrin monoclonal antibodies), immunosuppressants or systemic corticosteroids ...

10. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

    Previous exposure to anti-tumor necrosis factor therapy. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...